Free Investment Report Watches Stocks Like Citigroup Inc. and Bank of America Continue to Flounder While GENova Biotherapeutics Inc. Continues Its Massive Run


LAS VEGAS, Sept. 15, 2009 (GLOBE NEWSWIRE) -- The market continues to tread water in early trading Tuesday even as fears of a full-scale trade war with China lessened. Free Investment Report is watching stocks market-wide in order to provide our subscriber base with the next winning investment idea. In the past several days, there have been some major and impressive micro and small cap companies that have netted investors substantial profits. In order to receive our detailed reports FREE of charge and start cashing in, simply visit us at

Day after day we continue to see Wall Street brokers recommending that their clients buy stocks like Citigroup Inc. and Bank of America. Sure, their long-term outlooks are substantially better than they were just a few short months ago, but we continue to see more impressive gains in the micro and small cap markets.

Our core investment philosophy is that "Small Cap Is the New Big." How many investors can say that they believe either Citigroup Inc. or Bank of America Corp. will have the potential to return gains like GENova Biotherapeutics Inc.?

GENova Biotherapeutics Inc. is exactly what our company philosophy is all about. On September 4, 2009, GENova Biotherapeutics opened trading at $0.10 a share and today, just eight trading days later, is trading as high as $0.635 -- a whopping gain of over 530%!

Why not get plugged into an area of the market that can produce these types of gains in days? Afford us the opportunity to show you the type of gains that are possible in the micro and small cap markets. Thousands of subscribers continue to give us their confidence and sign up. We provide our subscribers with trustworthy insightful due diligence on small- to medium-sized companies that are leaders in their sectors. Interested investors simply need to visit us at and sign up today for free. It is time to start making money in the markets! Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. is a wholly owned entity of a financial public relations firm. Please read our report and visit our website for complete risks and disclosures.


Contact Data